93Indexed trials
Market Rank #30 · Evidence Tier A
Argentina
Neuroscience Intelligence
Argentina neuroscience intelligence: 93 indexed trials, 49 institutions, research score 34.49.
30Recruiting
49Research institutions
34.5Research score
Evidence profile
46Sponsors
17Disease areas
0Institution works
0Institution citations
Evidence signals
Research score 34.5 · Data confidence 100.00 · Evidence 34.5
Data confidence measures presence of evidence layers, not a probability of success. Scores are comparative decision-support signals, not guaranteed market size or commercial outcomes.
Leading disease areas
alzheimers25trials
parkinsons14trials
epilepsy10trials
multiple_sclerosis7trials
schizophrenia7trials
other_neurology5trials
depression5trials
neuromuscular4trials
migraine_headache3trials
stroke3trials
Leading indexed sponsors
Merck Sharp & Dohme LLC12trials
Hoffmann-La Roche12trials
Eli Lilly and Company5trials
GlaxoSmithKline5trials
Pfizer4trials
Washington University School of Medicine3trials
Genzyme, a Sanofi Company3trials
Boehringer Ingelheim3trials
Novartis Pharmaceuticals3trials
Janssen Research & Development, LLC2trials